← SynDRA
BETRIXABAN
SynDRA canonical compound SYN0012009 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | F10 |
|---|
| Mechanism of action | Coagulation inhibitor |
|---|
| Indication | deep vein thrombosis (DVT) |
|---|
| Disease area | hematology |
|---|
All known targets
Mechanisms of action (all sources)
- Coagulation inhibitor
- F10 INHIBITOR
- Coagulation factor X inhibitor
- coagulation factor inhibitor
- F10 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Anticoagulants
- Antithrombins
- Enzyme Inhibitors
- Factor Xa Inhibitors
- Hematologic Agents
- Protease Inhibitors
- Serine Proteinase Inhibitors
- Factor Xa Inhibitor
ATC classes
- B01A · ANTITHROMBOTIC AGENTS
Cross-references
Synonyms
- BEVYXXA
- PRT054021
- betrixaban maleate
- bevyxxa
- Betrixaban maleate
- PRT-054021
- Bevyxxa
- UNII-74RWP7W0J9
- PRT 054021
- 74RWP7W0J9
- Betrixaban [USAN:INN]
- betrixaban/
- Betrixaban (USAN)
- SCHEMBL158591
- QCR-99
- GTPL9602
- EX-A358
- MolPort-009-682-948
- ZINC3
- CHEBI:140421
- betrixabanum
- RefChem:58846
- B01AF04
- DTXCID801382738
- MFCD16038040
- Betrixaban [USAN]
- Betrixaban?
- Bevyxxa (TN)
- BETRIXABAN [MI]
- BETRIXABAN [INN]
- BETRIXABAN [WHO-DD]
- Betrixaban - Bio-X trade mark
- orb1690000
- BETRIXABAN [ORANGE BOOK]
- SCHEMBL29374026
- GLXC-90253
- HMS5084I16
Look up BETRIXABAN in the interactive SynDRA portal →